Axel H.
- Country
- Germany
- Department
- Klinik für Urologie, Uro-Onkologie, spezielle urologische und roboter-assistierte Chirurgie
Research Overview
- Phase 3 Randomized, Double-blind, Placebo-controlled Study of Apalutamide and Androgen Deprivation Therapy in High-risk Localized or Locally Advanced Prostate Cancer
- Efficacy and Safety of Durvalumab, Tremelimumab, and Enfortumab Vedotin in Perioperative Treatment of Cisplatin-Ineligible Muscle Invasive Bladder Cancer
- Efficacy and Safety of TAR-200 vs. Intravesical Chemotherapy in High-Risk Non-Muscle-Invasive Bladder Cancer Post-BCG Recurrence
Data & Insights
Has run more than one trial at 87 of 243 partner sites.
Specializations
Prostate Cancer Management
The investigator specializes in treating various stages of prostate cancer, with particular focus on hormone-sensitive prostate cancer and biochemically recurrent disease.
- Metastatic hormone-sensitive prostate cancer therapy
- High-risk localized prostate cancer treatment
- Androgen deprivation therapy combinations
Their expertise extends to novel therapeutic approaches incorporating hormone therapy and targeted treatments for advanced disease states.
Bladder Cancer Treatment
The investigator demonstrates significant expertise in managing bladder cancer across different stages, with specialized focus on non-muscle invasive bladder cancer.
- High-risk NMIBC management
- BCG-unresponsive disease treatment
- Muscle invasive bladder cancer therapy
Their work encompasses both intravesical treatments and systemic therapeutic approaches for various bladder cancer presentations.
Advanced Therapeutic Approaches
The investigator works with innovative therapeutic combinations including immunotherapy and targeted molecular treatments.
- Novel drug combinations
- Precision medicine applications
- Treatment optimization strategies
Their research integrates multiple therapeutic modalities for treating complex urological malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.